Browsing: pancreatic cancer

The first large prospective study of 136 patients across 13 institutions receiving SMART for pancreatic cancer achieved local control in…

The outcomes of the Chinese phase 3 NOTABLE trial that demonstrated across 92 patients with KRAS-wildtype unresectable and/or metastatic pancreatic…

This case report describes an exciting (although n=1) response to T-cell receptor gene therapy in a patient with refractory, metastatic…